Bio-View Ltd (TLV:BIOV)

Market Cap	23.45M -37.6%
Revenue (ttm)	17.88M -47.9%
Net Income	-9.67M
EPS	-0.07
Shares Out	134.01M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	251
Average Volume	307,287
Open	17.90
Previous Close	17.50
Day's Range	17.90 - 17.90
52-Week Range	12.90 - 36.00
Beta	-0.31
RSI	50.82
Earnings Date	Mar 26, 2026

About Bio-View

Bio-View Ltd develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally. The company’s products include Accord, a workbench microscope station for semi-automated fluorescent imaging and analysis; Accord Plus, an automatic fluorescent imaging system that automatically scans, analyses, and sorts a range of FISH and Karyotype samples in real-time; and Allegro Plus, an automatic imaging system, which identifies var...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 33
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: BIOV